Alexion Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Alexion Pharmaceuticals patents 113 in total
| Status | Patent |
|---|---|
Grant | Utility: Cerdulatinib for treating hematological cancers Filling date: 6 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Anti-C5 antibodies having improved pharmacokinetics Filling date: 6 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Bis-choline tetrathiomolybdate for treating Wilson Disease Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Inhibitors of protein kinases Filling date: 6 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Anti-C5A antibodies Filling date: 6 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Methods for treating lysosomal acid lipase deficiency in patients Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Methods for treating craniosynostosis in a patient Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: METHODS OF TREATING VITILIGO USING AN ANTI-C5 ANTIBODY Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: High concentration anti-C5 antibody formulations Filling date: 6 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Manufacturing of alkaline phosphatases Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: MONOVALENT ANTI-PROPERDIN ANTIBODIES AND ANTIBODY FRAGMENTS Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Grant | Utility: Synthesis of cerdulatinib Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: MANUFACTURING OF GLYCOPROTEINS Filling date: 6 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: ANTI-ALK2 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 31 Mar 2022 |
Grant | Utility: Methods for treating lymphoma Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Bone delivery conjugates and method of using same to target proteins to bone Filling date: 6 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Filling date: 6 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasia Filling date: 6 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Treating seizure with recombinant alkaline phosphatase Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Grant | Utility: Methods for treating hypophosphatasia (HPP) in adults and adolescents Filling date: 6 Sep 2025 Issue date: 18 Jan 2022 |
Application | Utility: SUBCUTANEOUS DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Methods of treating age-related macular degeneration in a patient comprising administering an anti-C5a antibody Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Monovalent anti-properdin antibodies and antibody fragments Filling date: 6 Sep 2025 Issue date: 14 Dec 2021 |
Application | Utility: INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVATIVES Filling date: 6 Sep 2025 Issue date: 9 Dec 2021 |
Grant | Utility: Treating muscle weakness with alkaline phosphatases Filling date: 6 Sep 2025 Issue date: 30 Nov 2021 |
Application | Utility: ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME Filling date: 6 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) IN PEDIATRIC PATIENTS Filling date: 6 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Method of purifying a heterologous protein from an egg white Filling date: 6 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: MANUFACTURING OF GLYCOPROTEINS Filling date: 6 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS Filling date: 6 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Methods for treating tracheobronchomalacia Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Method for simultaneous quantification of ALXN1210 and eculizumab in human serum or urine Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Methods of replicating a large scale eculizumab production cell culture Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: ANTIBODY IMMUNE CELL INHIBITOR FUSION PROTEINS Filling date: 6 Sep 2025 Issue date: 26 Aug 2021 |
Grant | Utility: Methods for treating hypophosphatasia in children Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Application | Utility: COMPOSITIONS COMPRISING AN ANTI-C5 ANTIBODY Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF KIDNEY TRANSPLANT Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: METHODS FOR TREATING DISEASES ASSOCIATED WITH CILIOPATHIES Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: BIODEGRADABLE ACTIVATED POLYMERS FOR THERAPEUTIC DELIVERY Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: LYSOSOMAL STORAGE DISEASE ENZYMES Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Grant | Utility: Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: METHODS OF TREATING NEUROFIBROMATOSIS TYPE 1 AND RELATED CONDITIONS WITH ALKALINE PHOSPHATASE Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: SOLID FORMS OF CERDULATINIB Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF PRODUCING ANTI-C5 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 29 Apr 2021 |
Showing 1 to 50 of 113 patents.